Last update 29 Dec 2025

Isorhamnetin 3-O-glucoside

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
JAK2 x VEGFR1
Action
inhibitors, modulators
Mechanism
JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), VEGFR1 modulators(Vascular endothelial growth factor receptor 1 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesDigestive System Disorders+ [2]
Active Indication
Colitis, UlcerativeBreast CancerProstatic Cancer
Inactive Indication-
Originator Organization
Kermanshah University of Medical SciencesKermanshah University of Medical Sciences
Active Organization
Kermanshah University of Medical SciencesKermanshah University of Medical SciencesAnhui Jiuhua Huayuan Pharmaceutical Co., Ltd.Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.Anhui University of Science & TechnologyAnhui University of Science & Technology
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Isorhamnetin 3-O-glucoside
Login to view more data
100 Translational Medicine associated with Isorhamnetin 3-O-glucoside
Login to view more data
100 Patents (Medical) associated with Isorhamnetin 3-O-glucoside
Login to view more data
100 Deals associated with Isorhamnetin 3-O-glucoside
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colitis, UlcerativePreclinical
China
Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.
01 Nov 2025
Colitis, UlcerativePreclinical
China
Anhui University of Science & TechnologyAnhui University of Science & Technology
01 Nov 2025
Breast CancerPreclinical
Iran
Kermanshah University of Medical SciencesKermanshah University of Medical Sciences
01 Oct 2025
Prostatic CancerPreclinical
Iran
Kermanshah University of Medical SciencesKermanshah University of Medical Sciences
01 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free